Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement

Robert W. Schrier; Sally Burrows-Hudson; Louis Diamond; A. Peter Lundin; Maureen Michael; Donald L. Patrick; Thomas G. Peters; Neil R. Powe; James S. Roberts; John H. Sadler; Albert L. Siu; Kathleen N. Lohr; Richard A. Rettig

doi:10.1016/S0272-6386(12)80206-X

Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement

Robert W. Schrier, Sally Burrows-Hudson, Louis Diamond, A. Peter Lundin, Maureen Michael, Donald L. Patrick, Thomas G. Peters, Neil R. Powe, James S. Roberts, John H. Sadler, Albert L. Siu, Kathleen N. Lohr, Richard A. Rettig

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.

Original language	English (US)
Pages (from-to)	383-388
Number of pages	6
Journal	American Journal of Kidney Diseases
Volume	24
Issue number	2
DOIs	https://doi.org/10.1016/S0272-6386(12)80206-X
State	Published - 1994
Externally published	Yes

Keywords

End-stage renal disease treatment
quality of care
quality of life

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/S0272-6386(12)80206-X

Cite this

Schrier, R. W., Burrows-Hudson, S., Diamond, L., Lundin, A. P., Michael, M., Patrick, D. L., Peters, T. G., Powe, N. R., Roberts, J. S., Sadler, J. H., Siu, A. L., Lohr, K. N., & Rettig, R. A. (1994). Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement. American Journal of Kidney Diseases, 24(2), 383-388. https://doi.org/10.1016/S0272-6386(12)80206-X

Schrier, RW, Burrows-Hudson, S, Diamond, L, Lundin, AP, Michael, M, Patrick, DL, Peters, TG, Powe, NR, Roberts, JS, Sadler, JH, Siu, AL, Lohr, KN & Rettig, RA 1994, 'Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement', American Journal of Kidney Diseases, vol. 24, no. 2, pp. 383-388. https://doi.org/10.1016/S0272-6386(12)80206-X

@article{39385c347a274e43831490c212b1c28a,

title = "Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement",

abstract = "The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.",

keywords = "End-stage renal disease treatment, quality of care, quality of life",

author = "Schrier, {Robert W.} and Sally Burrows-Hudson and Louis Diamond and Lundin, {A. Peter} and Maureen Michael and Patrick, {Donald L.} and Peters, {Thomas G.} and Powe, {Neil R.} and Roberts, {James S.} and Sadler, {John H.} and Siu, {Albert L.} and Lohr, {Kathleen N.} and Rettig, {Richard A.}",

year = "1994",

doi = "10.1016/S0272-6386(12)80206-X",

language = "English (US)",

volume = "24",

pages = "383--388",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting

T2 - Committee Statement

AU - Schrier, Robert W.

AU - Burrows-Hudson, Sally

AU - Diamond, Louis

AU - Lundin, A. Peter

AU - Michael, Maureen

AU - Patrick, Donald L.

AU - Peters, Thomas G.

AU - Powe, Neil R.

AU - Roberts, James S.

AU - Sadler, John H.

AU - Siu, Albert L.

AU - Lohr, Kathleen N.

AU - Rettig, Richard A.

PY - 1994

Y1 - 1994

N2 - The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.

AB - The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.

KW - End-stage renal disease treatment

KW - quality of care

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=0028075249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028075249&partnerID=8YFLogxK

U2 - 10.1016/S0272-6386(12)80206-X

DO - 10.1016/S0272-6386(12)80206-X

M3 - Article

C2 - 8048448

AN - SCOPUS:0028075249

SN - 0272-6386

VL - 24

SP - 383

EP - 388

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 2

ER -

Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this